Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Research Report 2024

Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Trends

The diagnosis of Postural Orthostatic Tachycardia Syndrome (POTS) has significantly increased due to advances in medical research and increased awareness among healthcare practitioners. There is now a greater need for treatment choices as a result of the condition's improved identification and comprehension brought about by this enhanced knowledge. Furthermore, because POTS is frequently misdiagnosed or left untreated, increased knowledge has encouraged people with symptoms like fainting, dizziness, and a fast heartbeat to seek medical assistance, which has helped the market for POTS treatments develop.

The market for POTS treatments has grown significantly as a result of continuous research and development aimed at improving treatment options. More efficient methods of treating POTS symptoms have been made possible by technological developments in medical equipment, including pacemakers, neuromodulation devices, and implanted cardioverter-defibrillators (ICDs). Additionally, to increase the range of therapy choices accessible to patients, pharmaceutical firms are investing in innovative medication treatments that address the underlying processes of post-oxygenase shock syndrome (POTS), such as autonomic dysfunction and deregulation of blood flow.

The market for treatments has expanded due to a noticeable rise in the occurrence of POTS, especially in younger populations. POTS has been associated with a number of factors in adolescents and young adults, including sedentary lifestyles, elevated stress levels, and an increase in autoimmune illnesses. An increasing need for specialized treatment strategies that address the particular physiological and lifestyle issues this demographic group faces is being driven by their desire to seek medical assistance for their symptoms. As a result, the market for POTS therapies is growing as a result of pharmaceutical firms and healthcare professionals concentrating on creating and providing cutting-edge treatments especially intended for younger patients.

The Postural Orthostatic Tachycardia Syndrome (POTS) therapy market is dominated by North America because of the region's sophisticated healthcare system, reputable medical research institutions, and high POTS case frequency. Prolonged awareness initiatives assist the region by encouraging early diagnosis and raising the demand for available treatment choices. Additionally, partnerships among pharmaceutical firms, academic institutions, and healthcare providers foster innovation in treatment approaches, which in turn accelerates market expansion. In addition, the market for POTS treatments is developing in North America due to favorable payment rules and an increasing focus on patient-centric care.

Scope of Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Primary Forms

1.2.3 Secondary Forms

1.3 Market by Application

1.3.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.3.5 Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Perspective (2019-2030)

2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Growth Trends by Region

2.2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Size by Region (2019-2024)

2.2.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Region (2025-2030)

2.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Dynamics

2.3.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Industry Trends

2.3.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Drivers

2.3.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Challenges

2.3.4 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Restraints

3.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Revenue

3.1.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Revenue (2019-2024)

3.1.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue

3.4 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio

3.4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2023

3.5 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players Head office and Area Served

3.6 Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service

3.7 Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Size by Type (2019-2024)

4.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Type (2025-2030)

5.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Size by Application (2019-2024)

5.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Application (2025-2030)

6.1 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2019-2030)

6.2 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2019-2024)

6.4 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7.1 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2019-2030)

7.2 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2019-2024)

7.4 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2019-2030)

8.2 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2019-2030)

9.2 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2019-2024)

9.4 Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2019-2030)

10.2 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction

11.1.4 Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Detail

11.2.2 Novartis Business Overview

11.2.3 Novartis Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction

11.2.4 Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

11.2.5 Novartis Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Detail

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction

11.3.4 AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

11.3.5 AstraZeneca Recent Development

11.4 Merck

11.4.1 Merck Company Detail

11.4.2 Merck Business Overview

11.4.3 Merck Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction

11.4.4 Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

11.4.5 Merck Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction

11.5.4 Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

11.5.5 Sanofi Recent Development

11.6 Daiichi Sankyo

11.6.1 Daiichi Sankyo Company Detail

11.6.2 Daiichi Sankyo Business Overview

11.6.3 Daiichi Sankyo Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction

11.6.4 Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

11.6.5 Daiichi Sankyo Recent Development

11.7 Bayer

11.7.1 Bayer Company Detail

11.7.2 Bayer Business Overview

11.7.3 Bayer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction

11.7.4 Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

11.7.5 Bayer Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

    Table 2. Key Players of Primary Forms

    Table 3. Key Players of Secondary Forms

    Table 4. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

    Table 5. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 6. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2019-2024) & (US$ Million)

    Table 7. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Region (2019-2024)

    Table 8. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

    Table 9. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Region (2025-2030)

    Table 10. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Trends

    Table 11. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Drivers

    Table 12. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Challenges

    Table 13. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Restraints

    Table 14. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue by Players (2019-2024) & (US$ Million)

    Table 15. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players (2019-2024)

    Table 16. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2023)

    Table 17. Ranking of Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Companies by Revenue (US$ Million) in 2023

    Table 18. Global 5 Largest Players Market Share by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (CR5 and HHI) & (2019-2024)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service

    Table 21. Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2019-2024) & (US$ Million)

    Table 24. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Type (2019-2024)

    Table 25. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

    Table 26. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Type (2025-2030)

    Table 27. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2019-2024) & (US$ Million)

    Table 28. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Application (2019-2024)

    Table 29. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

    Table 30. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Application (2025-2030)

    Table 31. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 32. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2019-2024) & (US$ Million)

    Table 33. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2025-2030) & (US$ Million)

    Table 34. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 35. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2019-2024) & (US$ Million)

    Table 36. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2025-2030) & (US$ Million)

    Table 37. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

    Table 38. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2019-2024) & (US$ Million)

    Table 39. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Region (2025-2030) & (US$ Million)

    Table 40. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 41. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2019-2024) & (US$ Million)

    Table 42. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2025-2030) & (US$ Million)

    Table 43. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

    Table 44. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2019-2024) & (US$ Million)

    Table 45. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Country (2025-2030) & (US$ Million)

    Table 46. Pfizer Company Detail

    Table 47. Pfizer Business Overview

    Table 48. Pfizer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product

    Table 49. Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024) & (US$ Million)

    Table 50. Pfizer Recent Development

    Table 51. Novartis Company Detail

    Table 52. Novartis Business Overview

    Table 53. Novartis Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product

    Table 54. Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024) & (US$ Million)

    Table 55. Novartis Recent Development

    Table 56. AstraZeneca Company Detail

    Table 57. AstraZeneca Business Overview

    Table 58. AstraZeneca Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product

    Table 59. AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024) & (US$ Million)

    Table 60. AstraZeneca Recent Development

    Table 61. Merck Company Detail

    Table 62. Merck Business Overview

    Table 63. Merck Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product

    Table 64. Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024) & (US$ Million)

    Table 65. Merck Recent Development

    Table 66. Sanofi Company Detail

    Table 67. Sanofi Business Overview

    Table 68. Sanofi Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product

    Table 69. Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024) & (US$ Million)

    Table 70. Sanofi Recent Development

    Table 71. Daiichi Sankyo Company Detail

    Table 72. Daiichi Sankyo Business Overview

    Table 73. Daiichi Sankyo Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product

    Table 74. Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024) & (US$ Million)

    Table 75. Daiichi Sankyo Recent Development

    Table 76. Bayer Company Detail

    Table 77. Bayer Business Overview

    Table 78. Bayer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product

    Table 79. Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024) & (US$ Million)

    Table 80. Bayer Recent Development

    Table 81. Research Programs/Design for This Report

    Table 82. Key Data Information from Secondary Sources

    Table 83. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

    Figure 2. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type: 2023 VS 2030

    Figure 3. Primary Forms Features

    Figure 4. Secondary Forms Features

    Figure 5. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

    Figure 6. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application: 2023 VS 2030

    Figure 7. Hospitals Case Studies

    Figure 8. Clinics Case Studies

    Figure 9. Ambulatory Surgical Centers Case Studies

    Figure 10. Research Institutes Case Studies

    Figure 11. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Report Years Considered

    Figure 12. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

    Figure 13. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

    Figure 14. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Region: 2023 VS 2030

    Figure 15. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players in 2023

    Figure 16. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2023)

    Figure 17. The Top 10 and 5 Players Market Share by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2023

    Figure 18. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 19. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2019-2030)

    Figure 20. United States Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 21. Canada Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 22. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 23. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2019-2030)

    Figure 24. Germany Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 25. France Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 26. U.K. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 27. Italy Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 28. Russia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 29. Nordic Countries Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 30. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 31. Asia-Pacific Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Region (2019-2030)

    Figure 32. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 33. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 34. South Korea Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 35. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 36. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 37. Australia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 38. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 39. Latin America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2019-2030)

    Figure 40. Mexico Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 41. Brazil Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 42. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 43. Middle East & Africa Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Country (2019-2030)

    Figure 44. Turkey Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 45. Saudi Arabia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

    Figure 46. Pfizer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

    Figure 47. Novartis Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

    Figure 48. AstraZeneca Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

    Figure 49. Merck Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

    Figure 50. Sanofi Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

    Figure 51. Daiichi Sankyo Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

    Figure 52. Bayer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2019-2024)

    Figure 53. Bottom-up and Top-down Approaches for This Report

    Figure 54. Data Triangulation

    Figure 55. Key Executives Interviewed